Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia.
Zhou L, Ni C, Liao R, Tang X, Yi T, Ran M, Huang M, Liao R, Zhou X, Qin D, Wang L, Huang F, Xie X, Wan Y, Luo J, Wang Y, Wu J.
Zhou L, et al. Among authors: huang m, huang f.
Elife. 2024 Apr 4;13:RP94765. doi: 10.7554/eLife.94765.
Elife. 2024.
PMID: 38573820
Free PMC article.